Images are illustrative. Actual specifications are as selected and confirmed in writing.
GLP-1 & Metabolic Research
Semaglutide
10mg/vial x 10vials
US$90.91
KLOW80Images are illustrative. Actual specifications are as selected and confirmed in writing.
Dermal & Aesthetic Research
KLOW-80
Combination for skin and soft-tissue repair research
KLOW-80 specifications and reference prices. Select a specification to add it to your cart.
GHK-CU+TB-500+BPC157+KPV (50mg+10mg+10mg+10mg)/vial x 10vials
Reference priceUS$400
For laboratory research only. Not for human or veterinary use.
COA 检测报告 / Reports
Compare all specifications & reference prices
| SKU | Specification / pack | Reference price (USD) |
|---|---|---|
| KLOW80 | GHK-CU+TB-500+BPC157+KPV (50mg+10mg+10mg+10mg)/vial x 10vials | US$400 |
Temporarily sold-out specifications can still be added to an inquiry to ask about restocking. An inquiry is not an order or an agreed price.
Explore Dermal & Aesthetic Research ↗ · View all products
RESEARCH FOCUS
Main Uses & FAQs
This page uses skin and soft tissue repair compound as the direction for data checking. No qualified primary literature directly applicable to the main use of this product has been screened; related background does not serve as verification of product efficacy.
Main TopicsSkin · Soft Tissue Repair Compound
USAGE REFERENCE
KLOW-80 · Usage reference (for research purposes)
The following presents common research-context references for reconstitution, storage, dosage and cycles. The following presents common references in research settings. This page does not constitute advice for use in humans or animals.
🧪Reconstitution
- Suggested Diluent
- Bacteriostatic Water (containing 0.9% benzyl alcohol); some peptides may use sterile water or acetic acid to aid dissolution. See the individual product descriptions.
- Diluent Volume
- Slowly introduce the diluent along the vial wall until the lyophilized powder is covered. A common example is 5 mg reconstituted with 2 mL of bacteriostatic water, yielding approximately 2.5 mg/mL. Referenced reconstitution volumes are approximately 1–2.5 mL, with 2 mL commonly used. It is suggested to select and record a fixed volume based on the COA supplied with the purchase.
- Handling Notes
- Introduce the diluent slowly along the vial wall rather than directly onto the lyophilized powder. Leave it for 60–90 seconds to dissolve naturally; do not shake vigorously.
💾Storage
- Unreconstituted Lyophilized Powder
- Refrigerate at 2–8°C, protected from light; avoid repeated freeze–thaw cycles.
- After Reconstitution
- Refrigerate at 2–8°C; a common recommendation is touse within 28 days; do not freeze.
- Transport
- For short periods, use insulated packaging with ice packs; avoid high temperatures and direct light.
📏Dosage Reference (Research)
| Purpose / Setting | Common Reference |
|---|---|
| Explanation | Skin Repair Compound, Identity Pending Verification |
Note: The above describes common research-context references, rather than clinical recommendations. Refer to the batch COA and research protocol. For research use only; not for human or animal use.
References
Read the Full Research Review ↗Evidence and Identity VerificationKey Findings
What usage claims can KLOW-80 currently support?
The specifications and research directions pending verification in the catalog can be explained, but this cannot be used to give a definite promise of effects in humans or animals. No. Adding KPV changes the components and proportions, so one cannot apply another compound formulation, nor combine four single-drug studies to validate a 50:10:10:10 formulation.
Before ReadingStudy populations, species, formulations and delivery conditions each have a defined scope. Research on an ingredient does not establish that this site's product batches have been validated for efficacy in humans or veterinary use.
Identity / formulation must be verified
Qualified direct in vivo main literature has not yet been screened
Not possible. After adding KPV, the ingredients and ratios change; another compound cannot be applied, nor can four separate single-drug studies be combined to validate a 50:10:10:10 formula.
See common questions about this product ↓No. After adding KPV, the composition and ratios change, so it cannot be applied to another compound, nor can the four single-drug studies be simply summed to verify a 50:10:10:10 formula. This page is a curated collection of purpose-oriented positive data, not a systematic review or dosing recommendation. Historical studies, combination formulations, and special models are individually noted.
GO DEEPER
↗What Questions Do These Studies Address?
Compare study populations, findings and scope.
KLOW-80 · Frequently Asked Questions.
Can KLOW-80 directly inherit the effects of GLOW-70?＋
Not possible. After adding KPV, the ingredients and ratios change; another compound cannot be applied, nor can four separate single-drug studies be combined to validate a 50:10:10:10 formula.
Current status of data / procurement verification, not efficacy conclusions.KLOW-80 Why aren’t 3–5 efficacy papers listed?＋
At this stage, no sufficient qualified original studies have been screened that simultaneously correspond to commercial identity, main research purpose, and intervention form. Papers with similar names, single components, or other purposes cannot be used to supplement the data.
Current status of data / procurement verification, not efficacy conclusions.What materials are needed when reviewing KLOW-80 study materials?＋
The full name, CAS or sequence, modifications/salt form, component ratio, source, and SKU batch COA should first be verified, then compared item by item with the paper materials.
Current status of data / procurement verification, not efficacy conclusions.VENTRO PEPTIDES & BIOTECH · RESEARCH PRODUCT RETAIL
Research peptides. Shop by product.
Compare specifications, reference prices and COA reports. Add products to your cart to request a quote.
QUALITY DOCUMENTSCOA BY PRODUCTGLOBAL DELIVERYTECHNICAL SUPPORT
01 / CATALOG
Browse products
Images are illustrative. Actual specifications are as selected and confirmed in writing.
GLP-1 & Metabolic Research
Tirzepatide
20mg/vial x 10vials
US$160.61
Images are illustrative. Actual specifications are as selected and confirmed in writing.
GLP-1 & Metabolic Research
Retatrutide
10mg/vial x 10vials
US$109.09
Images are illustrative. Actual specifications are as selected and confirmed in writing.
Repair & Recovery Research
BPC157
10mg/vial x 10vials
US$133.33
Images are illustrative. Actual specifications are as selected and confirmed in writing.
Longevity & Mitochondrial Research
MOTS-C
20mg/vial x 10vials
US$257.58
Images are illustrative. Actual specifications are as selected and confirmed in writing.
GLP-1 & Metabolic Research
Liraglutide
10mg*10vials
US$164.71
Images are illustrative. Actual specifications are as selected and confirmed in writing.
Growth Hormone & IGF-1
IGF-lr3
1mg/vial x 10vials
US$505.8802 / DISCOVER
Browse categories
01 / 04
03 / ABOUT VENTRO
Reliable peptide supply, built for long-term partnerships.
Ventro supports research product retail purchases with clear pack specifications, available quality documents, and responsive international support.
- High-purity peptides
- Available COA reports
- COA & quality documentation
- Flexible small-quantity purchases
- Reliable global fulfillment
- Research product retail support
04 / QUALITY SYSTEM
Quality without compromise
Browse the available COA reports by product. Confirm documentation for your order with our team.
Controlled quality workflowRaw material to final release
Responsive global supportProduct matching and technical support
RESEARCH PRODUCT INQUIRY
Submit a product inquiry
Tell us the product, specification, and expected quantity. Our team will respond with pricing and available documents.